South Korea Botulinum Toxin Market Size & Outlook
South Korea botulinum toxin market, 2018-2030 (US$M)
Related Markets
South Korea botulinum toxin market highlights
- The South Korea botulinum toxin market generated a revenue of USD 305.4 million in 2023 and is expected to reach USD 653.9 million by 2030.
- The South Korea market is expected to grow at a CAGR of 11.5% from 2024 to 2030.
- In terms of segment, type a was the largest revenue generating product in 2023.
- Type A is the most lucrative product segment registering the fastest growth during the forecast period.
Botulinum toxin market data book summary
| Market revenue in 2023 | USD 305.4 million |
| Market revenue in 2030 | USD 653.9 million |
| Growth rate | 11.5% (CAGR from 2023 to 2030) |
| Largest segment | Type a |
| Fastest growing segment | Type A |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Type A, Type B |
| Key market players worldwide | Ipsen SA, Merz Pharma, US WorldMeds, Galderma Group AG Registered Shares, Evolus Inc, Allergan, Metabiologics, Lanzhou Institute Of Biological Products |
Other key industry trends
- In terms of revenue, South Korea accounted for 2.8% of the global botulinum toxin market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, China botulinum toxin market is projected to lead the regional market in terms of revenue in 2030.
- China is the fastest growing regional market in Asia Pacific and is projected to reach USD 1,443.0 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Botulinum Toxin Market Scope
Botulinum Toxin Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
South Korea botulinum toxin market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to botulinum toxin market will help companies and investors design strategic landscapes.
Type a was the largest segment with a revenue share of 98.85% in 2023. Horizon Databook has segmented the South Korea botulinum toxin market based on type a, type b covering the revenue growth of each sub-segment from 2018 to 2030.
In South Korea, external appearance of an individual is linked to their social status and success. Furthermore, cosmetic treatment is, in some cases, sponsored by parents as gifts to their children on graduation or on attaining legal adult age, while in other cases, cosmetic treatment is considered to improve professional as well as personal relations & opportunities.
South Korea is the 8th largest esthetic market in the world, with the highest number of esthetic procedures per capita globally and there are 600+ clinics in Seoul alone. Key market drivers include rising medical tourism in South Korea, increasing public awareness about cosmetic procedures, availability of technologically advanced products and increasing geriatric population.
The cost of treatment in South Korea is less as compared to the U.S., Japan, and China, which is a contributing factor for the growth of non-invasive esthetic treatment market. Aesthetic regulations in Korea are not very stringent and there are a diverse range of treatment options for noninvasive procedures.
Reasons to subscribe to South Korea botulinum toxin market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of South Korea botulinum toxin market databook
-
Our clientele includes a mix of botulinum toxin market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the South Korea botulinum toxin market , including forecasts for subscribers. This country databook contains high-level insights into South Korea botulinum toxin market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
South Korea botulinum toxin market size, by product, 2018-2030 (US$M)
South Korea Botulinum Toxin Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
